European Union - English - EMA (European Medicines Agency)

virbac s.a. - tulathromycin - antibacterials for systemic use - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. the product should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

ceva santé animale - tulathromycin - antibacterials for systemic use - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. the product should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

vetoquinol - tulathromycin - antibacterials for systemic use - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. the product should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

vmd n.v. - tulathromycin - antibacterials for systemic use, macrolides - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. the product should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

dechra regulatory b.v. - tulathromycin - antibacterials for systemic use - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. the product should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - clostridium perfringens type d, strain 603 epsilon toxoid; clostridium septicum s1110/85 toxoid; clostridium tetani, strain 51123/91 toxoid; clostridium chauvoei strain no. 655; clostridium chauvoei strain no. 656; clostridium chauvoei strain no. 657; clostridium chauvoei strain no. 658; clostridium chauvoei strain no. 1048; formalin killed cells of mannheimia haemolytica serotypes a1; formalin killed cells of mannheimia haemolytica serotypes a2; formalin killed cells of mannheimia haemolytica serotypes a6; formalin killed cells of mannheimia haemolytica serotypes a7; formalin killed cells of mannheimia haemolytica serotypes a9; formalin killed cells of pasteurella trehalosi serotypes t3; formalin killed cells of pasteurella trehalosi serotypes t4; formalin killed cells of pasteurella trehalosi serotypes t10; formalin pasteurella trehalosi strain t15 (s1105/84) - suspension for injection - . - clostridium + pasteurella - sheep - immunological - inactivated vaccine

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - inactivated bovine herpes virus type 1.2b; inactivated mannheimia haemolytica strain x387; inactivated m. haemolytica leucotoxin strain x332 - misc. vaccines or anti sera - inactivated bovine herpes virus type 1.2b vaccine-viral active 0.0 m org/ml; inactivated mannheimia haemolytica strain x387 vaccine - general active 0.0 m org/ml; inactivated m. haemolytica leucotoxin strain x332 vaccine - general active 1.0e8 orgs/ml - immunotherapy - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - bovine herpesvirus | bovine respiratory disease | shipping fever

United Kingdom - English - VMD (Veterinary Medicines Directorate)

zoetis uk limited - mannheimia haemolytica - emulsion for injection - inactivated bacterial vaccine - cattle

United Kingdom - English - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - clostridium chauvoei, clostridium novyi, clostridium perfringens, clostridium septicum, clostridium tetani, mannheimia haemolytica, pasteurella trehalosi - suspension for injection - inactivated bacterial vaccine - sheep

United Kingdom - English - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - clostridium chauvoei, clostridium novyi, clostridium perfringens, clostridium septicum, clostridium tetani, mannheimia haemolytica, pasteurella trehalosi - suspension for injection - inactivated bacterial vaccine - sheep